These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38155038)

  • 21. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolutionary role of the IL-33/ST2 system in host immune defence.
    Sattler S; Smits HH; Xu D; Huang FP
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):107-17. PubMed ID: 23283516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
    Cayrol C; Girard JP
    Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia.
    Fattori V; Hohmann MSN; Rossaneis AC; Manchope MF; Alves-Filho JC; Cunha TM; Cunha FQ; Verri WA
    Expert Opin Ther Targets; 2017 Dec; 21(12):1141-1152. PubMed ID: 29076792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
    Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
    Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Functions of IL-33 in Homeostasis and Immunity.
    Dwyer GK; D'Cruz LM; Turnquist HR
    Annu Rev Immunol; 2022 Apr; 40():15-43. PubMed ID: 34985928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
    Cayrol C
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives.
    Ramezani F; Babaie F; Aslani S; Hemmatzadeh M; Mohammadi FS; Gowhari-Shabgah A; Jadidi-Niaragh F; Ezzatifar F; Mohammadi H
    Immunol Invest; 2022 May; 51(4):1060-1086. PubMed ID: 33522348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.
    Rostan O; Arshad MI; Piquet-Pellorce C; Robert-Gangneux F; Gangneux JP; Samson M
    Infect Immun; 2015 May; 83(5):1738-48. PubMed ID: 25712928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin (IL)-33: an orchestrator of immunity from host defence to tissue homeostasis.
    Zhou Z; Yan F; Liu O
    Clin Transl Immunology; 2020; 9(6):e1146. PubMed ID: 32566227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conflicting vascular and metabolic impact of the IL-33/sST2 axis.
    Altara R; Ghali R; Mallat Z; Cataliotti A; Booz GW; Zouein FA
    Cardiovasc Res; 2018 Oct; 114(12):1578-1594. PubMed ID: 29982301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome.
    Soyfoo MS; Nicaise C
    Autoimmun Rev; 2021 Mar; 20(3):102756. PubMed ID: 33476812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of IL-33/ST2 signaling in the tumor microenvironment and Treg immunotherapy.
    Lei S; Jin J; Zhao X; Zhou L; Qi G; Yang J
    Exp Biol Med (Maywood); 2022 Oct; 247(20):1810-1818. PubMed ID: 35733343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-33/ST2 as a potential target for tumor immunotherapy.
    Jiang W; Lian J; Yue Y; Zhang Y
    Eur J Immunol; 2021 Aug; 51(8):1943-1955. PubMed ID: 34131922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
    Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
    Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis.
    Vasanthakumar A; Kallies A
    Cold Spring Harb Perspect Biol; 2019 Mar; 11(3):. PubMed ID: 29101106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-33 biology in cancer: An update and future perspectives.
    Yeoh WJ; Vu VP; Krebs P
    Cytokine; 2022 Sep; 157():155961. PubMed ID: 35843125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
    Zeng S; Wu J; Liu J; Qi F; Liu B
    Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-33: increasing role in dermatological conditions.
    Balato A; Raimondo A; Balato N; Ayala F; Lembo S
    Arch Dermatol Res; 2016 Jul; 308(5):287-96. PubMed ID: 26969580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.